Trials / Conditions / Hyperlipoproteinemias
Hyperlipoproteinemias
6 registered clinical trials studyying Hyperlipoproteinemias.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies NCT05425745 | NewAmsterdam Pharma | Phase 3 |
| Completed | Evaluating the Impact of B Vitamin Supplementation (Soloways™) on Homocysteine and LDL-C Levels in Patients Wi NCT06163443 | S.LAB (SOLOWAYS) | N/A |
| Completed | A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70) NCT04516291 | Pfizer | Phase 2 |
| Completed | An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patie NCT00694109 | Kastle Therapeutics, LLC | Phase 3 |
| Completed | Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemi NCT00607373 | Kastle Therapeutics, LLC | Phase 3 |
| Completed | Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia NCT00477594 | Kastle Therapeutics, LLC | Phase 2 |